IOFLUPANE (123I) ROTOP

For more information contact us!

PRODUCT

Specifications

There are no special storage conditions required. Please refer to the radiation safety regulations of your country.

ACTIVITY

2.5 ml containing 185 MBq
5.0 ml containing 370 MBq

HALF LIFE I-123

13.2 hours

SHELF LIFE

2.5 ml // 7 hours from the reference time stated on the label
5.0 ml // 20 hours from the reference time stated on the label

Reference time: 01:00 p.m. CET on the day of delivery

GLOBAL

Logistics and Sales

High flexibility. 2.5 ml and 5.0 ml are manufactured from the same batch.
DAYS OF DELIVERY

Upon request

ORDER DEADLINE

3 working days before delivery

CALIBRATION TIME

01:00 p.m. CET on the day of delivery

STORAGE

This medicinal product does not require any special conditions. Local radiation protection regulations must be followed.

ABOUT ROTOP

Our Manufacturing Site

ROTOP Radiopharmacy is located in the former PET center of the Helmholtz-Zentrum Dresden-Rossendorf, Germany,  and was inaugurated in 2020. In the modernized building, there are three hot cells in which high activities of Iodine-123 can be processed and Ioflupane (123I) is manufactured under cGMP conditions. The proprietary API was developed and produced entirely in-house. This precursor is used for Ioflupane production and provided to third parties.

Ioflupane (123I) ROTOP is distributed in environmentally friendly Type-A packaging all over Europe and we hold marketing authorizations in more than ten European countries. In compliance with high radiation protection standards, we developed fully automated cGMP labeling and packaging software to package and deliver Ioflupane from Dresden, Germany.

CONTACT

Let’s Talk.

If you want to order Ioflupane please contact: ioflupane@rotop-pharmaka.com or contact our customer service team: customer.service@rotop-pharmaka.com.

    captcha

    Captcha:


    Ioflupane (123I) ROTOP is registered in the following countries:

    distribution map ioflupane europe

    Pharmacovigilance

    By reporting adverse drug reactions (ADRs), including suspected cases, you can help provide more information on the safety of this medicine. Please contact our Pharmacovigilance department: pharmacovigilance@rotop-pharmaka.com.

    CONTACT

    Let’s talk.

    If you want to order Ioflupane please contact: ioflupane@rotop-pharmaka.com or contact our customer service team customer.service@rotop-pharmaka.com

      captcha

      Captcha:


      Ioflupane (123I) ROTOP is registered in the following countries:

      distribution map ioflupane europe

      Pharmacovigilance

      By reporting adverse drug reactions (ADRs), including suspected cases, you can help provide more information on the safety of this medicine. Please contact our Pharmacovigilance Department: pharmacovigilance@rotop-pharmaka.com